SPINK2
Serine protease inhibitor Kazal-type 2
Also known as: HUSI-II, ISK2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P20155
- Gene
- SPINK2
- Ensembl
- ENSG00000128040
- Chromosome
- 4
- Canonical length
- 84 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted secreted proteins
- Subcellular location
- Acrosome,Equatorial segment
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a member of the family of serine protease inhibitors of the Kazal type (SPINK). The encoded protein acts as a trypsin and acrosin inhibitor in the genital tract and is localized in the spermatozoa. The protein has been associated with the progression of lymphomas. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2012]
Canonical amino-acid sequenceUniProt
84 residues, UniProt reviewed canonical sequence.
>P20155|SPINK2
1 MALSVLRLAL LLLAVTFAAS LIPQFGLFSK YRTPNCSQYR LPGCPRHFNP VCGSDMSTYA
61 NECTLCMKIR EGGHNIKIIR NGPCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SPINK2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 4,956 nTPM
Expression across tissuesHPA
Tissue
- epididymis: 4,956 nTPM
- testis: 330 nTPM
- seminal vesicle: 222 nTPM
- bone marrow: 13 nTPM
- choroid plexus: 9 nTPM
- heart muscle: 7.2 nTPM
Single-cell type
- epididymal principal cells: 27,209 nCPM
- late primary spermatocytes: 4,199 nCPM
- late spermatids: 2,160 nCPM
- early spermatids: 943 nCPM
- epididymal basal cells: 933 nCPM
- early primary spermatocytes: 657 nCPM
Immune cell
- NK-cell: 144 nTPM
- naive CD8 T-cell: 21 nTPM
- naive CD4 T-cell: 11 nTPM
- naive B-cell: 11 nTPM
- memory B-cell: 8.5 nTPM
- memory CD8 T-cell: 5.3 nTPM
Brain region
- choroid plexus: 3.7 nTPM
- midbrain: 0.7 nTPM
- thalamus: 0.6 nTPM
- cerebral cortex: 0.5 nTPM
- medulla oblongata: 0.5 nTPM
- pons: 0.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SPINK2.
Disease | AllUniProt
Conditions SPINK2 is implicated in, by any mechanism.
- Spermatogenic failure 29 (SPGF29) MIM:618091
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 23 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Spermatogenic failure 29
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.49
- gnomAD pLI
- 0.07
- gnomAD missense Z
- 0.66
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Kazal domain
- Kazal domain superfamily
- Kazal-type serine protease inhibitor domain
- Serine protease inhibitor Kazal-type 2
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SPINK2 as an antibody target. Whether an autoantibody or antibody against SPINK2 could matter depends on whether native SPINK2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SPINK2 is annotated as secreted, so native SPINK2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label SPINK2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...